Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 2
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study.
Conway A, Read P, Gilliver R, McNaughton T, Valerio H, Cunningham EB, Henderson C, Hadlow B, Molloy K, Doab A, Tillakeratne S, Pepolim L, Harrod ME, Dore GJ, Grebely J. Conway A, et al. Among authors: tillakeratne s. Viruses. 2022 Nov 7;14(11):2463. doi: 10.3390/v14112463. Viruses. 2022. PMID: 36366561 Free PMC article.
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study.
Valerio H, Alavi M, Law M, McManus H, Tillakeratne S, Bajis S, Martinello M, Matthews GV, Amin J, Janjua NZ, Krajden M, George J, Degenhardt L, Grebely J, Dore GJ. Valerio H, et al. Among authors: tillakeratne s. Clin Infect Dis. 2021 Dec 6;73(11):2037-2044. doi: 10.1093/cid/ciab526. Clin Infect Dis. 2021. PMID: 34107022
Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study.
Grebely J, Gilliver R, McNaughton T, Conway A, Cunningham E, Henderson C, Hadlow B, Molloy K, Doab A, Tillakeratne S, Pepolim L, Harrod ME, Dore GJ, Read P. Grebely J, et al. Among authors: tillakeratne s. Int J Drug Policy. 2023 Apr;114:103982. doi: 10.1016/j.drugpo.2023.103982. Epub 2023 Feb 28. Int J Drug Policy. 2023. PMID: 36863287 Free article.
Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to Diagnosis.
Grebely J, Catlett B, Jayasinghe I, Valerio H, Hajarizadeh B, Verich A, Cunningham P, Martinello M, Tillakeratne S, Silk D, Dore GJ, Applegate TL. Grebely J, et al. Among authors: tillakeratne s. J Infect Dis. 2020 Jun 11;221(12):2043-2049. doi: 10.1093/infdis/jiaa037. J Infect Dis. 2020. PMID: 31993636
Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Cheng Q, Valerio H, Cunningham EB, Shih STF, Silk D, Conway A, Treloar C, Murray C, Henderson C, Amin J, Read P, Dore GJ, Grebely J; ETHOS Engage Study Group. Cheng Q, et al. Value Health. 2024 Feb;27(2):216-225. doi: 10.1016/j.jval.2023.10.013. Epub 2023 Nov 10. Value Health. 2024. PMID: 37951538 Free article.